Structure

Physi-Chem Properties

Molecular Weight:  548.15
Volume:  520.491
LogP:  1.003
LogD:  0.085
LogS:  -1.795
# Rotatable Bonds:  11
TPSA:  220.51
# H-Bond Aceptor:  13
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.133
Synthetic Accessibility Score:  4.424
Fsp3:  0.346
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.436
MDCK Permeability:  3.169532283209264e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.441
20% Bioavailability (F20%):  0.991
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.074
Plasma Protein Binding (PPB):  92.13292694091797%
Volume Distribution (VD):  0.44
Pgp-substrate:  11.120035171508789%

ADMET: Metabolism

CYP1A2-inhibitor:  0.013
CYP1A2-substrate:  0.034
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.044
CYP2C9-inhibitor:  0.164
CYP2C9-substrate:  0.252
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.15
CYP3A4-inhibitor:  0.395
CYP3A4-substrate:  0.036

ADMET: Excretion

Clearance (CL):  4.803
Half-life (T1/2):  0.937

ADMET: Toxicity

hERG Blockers:  0.027
Human Hepatotoxicity (H-HT):  0.13
Drug-inuced Liver Injury (DILI):  0.914
AMES Toxicity:  0.524
Rat Oral Acute Toxicity:  0.077
Maximum Recommended Daily Dose:  0.706
Skin Sensitization:  0.919
Carcinogencity:  0.278
Eye Corrosion:  0.003
Eye Irritation:  0.035
Respiratory Toxicity:  0.067

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC192568

Natural Product ID:  NPC192568
Common Name*:   1-O-Trans-Caffeoyl-5-O-7,8-Dihydro-7Alpha-Methoxycaffeoylquinic Acid
IUPAC Name:   (1S,3R,4R,5R)-3-[(3S)-3-(3,4-dihydroxyphenyl)-3-methoxypropanoyl]oxy-1-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-4,5-dihydroxycyclohexane-1-carboxylic acid
Synonyms:  
Standard InCHIKey:  LJQOTSZZGZIZEG-OQJUOGDSSA-N
Standard InCHI:  InChI=1S/C26H28O13/c1-37-20(14-4-6-16(28)18(30)9-14)10-23(33)38-21-12-26(25(35)36,11-19(31)24(21)34)39-22(32)7-3-13-2-5-15(27)17(29)8-13/h2-9,19-21,24,27-31,34H,10-12H2,1H3,(H,35,36)/b7-3+/t19-,20+,21-,24-,26+/m1/s1
SMILES:  CO[C@H](c1ccc(c(c1)O)O)CC(=O)O[C@@H]1C[C@@](OC(=O)/C=C/c2ccc(c(c2)O)O)(C[C@H]([C@H]1O)O)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2349422
PubChem CID:   71719001
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000129] Alcohols and polyols
          • [CHEMONTID:0001292] Cyclic alcohols and derivatives
            • [CHEMONTID:0002509] Cyclitols and derivatives
              • [CHEMONTID:0002512] Quinic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33307 pimpinella brachycarpa Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[23462643]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 174890.0 nM PMID[458330]
NPT34 Cell Line BV-2 Mus musculus Activity = 93.2 % PMID[458330]
NPT34 Cell Line BV-2 Mus musculus IC50 = 4660.0 nM PMID[458330]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC192568 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471076
0.9643 High Similarity NPC472016
0.9643 High Similarity NPC220664
0.9643 High Similarity NPC192831
0.9643 High Similarity NPC277315
0.9643 High Similarity NPC37331
0.9643 High Similarity NPC284948
0.9643 High Similarity NPC258469
0.9643 High Similarity NPC303090
0.9643 High Similarity NPC319628
0.9643 High Similarity NPC43158
0.9571 High Similarity NPC35702
0.9571 High Similarity NPC224389
0.9571 High Similarity NPC477335
0.9571 High Similarity NPC297517
0.9571 High Similarity NPC13818
0.9571 High Similarity NPC471027
0.9571 High Similarity NPC206095
0.951 High Similarity NPC322660
0.9429 High Similarity NPC26241
0.9429 High Similarity NPC274891
0.9429 High Similarity NPC303683
0.9429 High Similarity NPC476819
0.9429 High Similarity NPC205751
0.9429 High Similarity NPC295492
0.9429 High Similarity NPC474875
0.9429 High Similarity NPC476820
0.9357 High Similarity NPC24295
0.9357 High Similarity NPC302857
0.9357 High Similarity NPC283560
0.9357 High Similarity NPC152942
0.9357 High Similarity NPC37250
0.9357 High Similarity NPC278068
0.9357 High Similarity NPC142703
0.9357 High Similarity NPC219428
0.9315 High Similarity NPC306343
0.9247 High Similarity NPC42464
0.9241 High Similarity NPC229264
0.9236 High Similarity NPC477333
0.92 High Similarity NPC473275
0.92 High Similarity NPC470896
0.9189 High Similarity NPC93498
0.9189 High Similarity NPC163883
0.9178 High Similarity NPC43123
0.9172 High Similarity NPC98356
0.9155 High Similarity NPC156709
0.9155 High Similarity NPC179505
0.9143 High Similarity NPC182217
0.9143 High Similarity NPC70680
0.9143 High Similarity NPC233350
0.9128 High Similarity NPC146277
0.9128 High Similarity NPC19380
0.9071 High Similarity NPC68517
0.9071 High Similarity NPC106406
0.9014 High Similarity NPC279676
0.9014 High Similarity NPC67349
0.9007 High Similarity NPC145425
0.9 High Similarity NPC155209
0.9 High Similarity NPC168799
0.8993 High Similarity NPC477334
0.898 High Similarity NPC221383
0.898 High Similarity NPC143892
0.898 High Similarity NPC283081
0.898 High Similarity NPC299090
0.8933 High Similarity NPC95498
0.8933 High Similarity NPC246566
0.8929 High Similarity NPC61
0.8929 High Similarity NPC25581
0.8929 High Similarity NPC5419
0.8929 High Similarity NPC18074
0.8926 High Similarity NPC32197
0.8904 High Similarity NPC114242
0.8904 High Similarity NPC50221
0.8874 High Similarity NPC44730
0.8867 High Similarity NPC252979
0.8867 High Similarity NPC300329
0.8857 High Similarity NPC198388
0.8844 High Similarity NPC53884
0.8844 High Similarity NPC258671
0.8803 High Similarity NPC474895
0.88 High Similarity NPC259576
0.88 High Similarity NPC221091
0.8776 High Similarity NPC226738
0.8776 High Similarity NPC121573
0.8776 High Similarity NPC190587
0.8776 High Similarity NPC22176
0.8776 High Similarity NPC304956
0.8767 High Similarity NPC477277
0.8767 High Similarity NPC477278
0.8759 High Similarity NPC288452
0.8759 High Similarity NPC289690
0.8701 High Similarity NPC134925
0.8699 High Similarity NPC38473
0.8699 High Similarity NPC477279
0.8693 High Similarity NPC477299
0.8684 High Similarity NPC106818
0.8667 High Similarity NPC472969
0.8667 High Similarity NPC142528
0.8654 High Similarity NPC44507
0.8652 High Similarity NPC217052
0.8652 High Similarity NPC329344
0.8652 High Similarity NPC32626
0.8652 High Similarity NPC237506
0.8649 High Similarity NPC470130
0.8649 High Similarity NPC474692
0.8649 High Similarity NPC160378
0.8649 High Similarity NPC183824
0.8645 High Similarity NPC40920
0.8645 High Similarity NPC223335
0.8636 High Similarity NPC203757
0.8627 High Similarity NPC327225
0.8627 High Similarity NPC87403
0.8618 High Similarity NPC140151
0.8616 High Similarity NPC471823
0.8609 High Similarity NPC476394
0.8609 High Similarity NPC98809
0.8608 High Similarity NPC272750
0.8608 High Similarity NPC134047
0.8608 High Similarity NPC223006
0.8608 High Similarity NPC173729
0.8592 High Similarity NPC108553
0.8592 High Similarity NPC318799
0.859 High Similarity NPC469654
0.8581 High Similarity NPC285550
0.8562 High Similarity NPC75695
0.8562 High Similarity NPC128403
0.8544 High Similarity NPC144557
0.8543 High Similarity NPC248257
0.8543 High Similarity NPC120621
0.8543 High Similarity NPC98009
0.8503 High Similarity NPC225036
0.8503 High Similarity NPC12218
0.8503 High Similarity NPC105525
0.8503 High Similarity NPC75763
0.85 High Similarity NPC475695
0.8497 Intermediate Similarity NPC243891
0.8491 Intermediate Similarity NPC227297
0.8487 Intermediate Similarity NPC92117
0.8487 Intermediate Similarity NPC75945
0.8481 Intermediate Similarity NPC112418
0.8472 Intermediate Similarity NPC471749
0.8466 Intermediate Similarity NPC476374
0.8452 Intermediate Similarity NPC125487
0.8452 Intermediate Similarity NPC281703
0.8446 Intermediate Similarity NPC9218
0.8442 Intermediate Similarity NPC227485
0.8442 Intermediate Similarity NPC476434
0.8442 Intermediate Similarity NPC267091
0.8438 Intermediate Similarity NPC471788
0.8435 Intermediate Similarity NPC239943
0.8435 Intermediate Similarity NPC284409
0.8431 Intermediate Similarity NPC473091
0.8428 Intermediate Similarity NPC471745
0.8425 Intermediate Similarity NPC156892
0.8421 Intermediate Similarity NPC28776
0.8421 Intermediate Similarity NPC473138
0.8421 Intermediate Similarity NPC1580
0.8418 Intermediate Similarity NPC471744
0.8414 Intermediate Similarity NPC135127
0.8411 Intermediate Similarity NPC473867
0.8408 Intermediate Similarity NPC472860
0.8408 Intermediate Similarity NPC226759
0.8405 Intermediate Similarity NPC476370
0.84 Intermediate Similarity NPC473090
0.8395 Intermediate Similarity NPC280493
0.8387 Intermediate Similarity NPC61152
0.8387 Intermediate Similarity NPC3746
0.8387 Intermediate Similarity NPC16024
0.8387 Intermediate Similarity NPC205037
0.8387 Intermediate Similarity NPC44260
0.8378 Intermediate Similarity NPC474784
0.8369 Intermediate Similarity NPC168653
0.8369 Intermediate Similarity NPC251407
0.8367 Intermediate Similarity NPC308976
0.8367 Intermediate Similarity NPC302583
0.8367 Intermediate Similarity NPC100558
0.8367 Intermediate Similarity NPC84789
0.8367 Intermediate Similarity NPC310252
0.8366 Intermediate Similarity NPC478242
0.8356 Intermediate Similarity NPC18646
0.8344 Intermediate Similarity NPC475058
0.8344 Intermediate Similarity NPC471405
0.8333 Intermediate Similarity NPC469888
0.8333 Intermediate Similarity NPC194095
0.8333 Intermediate Similarity NPC283041
0.8333 Intermediate Similarity NPC327032
0.8333 Intermediate Similarity NPC191046
0.8322 Intermediate Similarity NPC226855
0.8322 Intermediate Similarity NPC94810
0.8313 Intermediate Similarity NPC35167
0.8311 Intermediate Similarity NPC220942
0.8302 Intermediate Similarity NPC301089
0.8302 Intermediate Similarity NPC24164
0.8302 Intermediate Similarity NPC239966
0.8302 Intermediate Similarity NPC203020
0.8302 Intermediate Similarity NPC476373
0.8302 Intermediate Similarity NPC53889
0.8298 Intermediate Similarity NPC132921
0.8293 Intermediate Similarity NPC190003
0.8293 Intermediate Similarity NPC175107

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC192568 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9643 High Similarity NPD6190 Approved
0.8228 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8219 Intermediate Similarity NPD230 Phase 1
0.8193 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD7266 Discontinued
0.8165 Intermediate Similarity NPD3817 Phase 2
0.8113 Intermediate Similarity NPD3882 Suspended
0.8098 Intermediate Similarity NPD6166 Phase 2
0.8098 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD2801 Approved
0.7964 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD6797 Phase 2
0.795 Intermediate Similarity NPD7075 Discontinued
0.7937 Intermediate Similarity NPD5402 Approved
0.7925 Intermediate Similarity NPD1934 Approved
0.7917 Intermediate Similarity NPD7251 Discontinued
0.7892 Intermediate Similarity NPD3818 Discontinued
0.7875 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD6233 Phase 2
0.7812 Intermediate Similarity NPD6801 Discontinued
0.7784 Intermediate Similarity NPD3751 Discontinued
0.7771 Intermediate Similarity NPD1512 Approved
0.7765 Intermediate Similarity NPD7808 Phase 3
0.7764 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD6232 Discontinued
0.7756 Intermediate Similarity NPD6799 Approved
0.7756 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD7054 Approved
0.7714 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7685 Pre-registration
0.7692 Intermediate Similarity NPD7472 Approved
0.7692 Intermediate Similarity NPD7074 Phase 3
0.7688 Intermediate Similarity NPD8150 Discontinued
0.7688 Intermediate Similarity NPD4380 Phase 2
0.7683 Intermediate Similarity NPD6234 Discontinued
0.7677 Intermediate Similarity NPD4628 Phase 3
0.7651 Intermediate Similarity NPD3787 Discontinued
0.7643 Intermediate Similarity NPD1511 Approved
0.7633 Intermediate Similarity NPD5844 Phase 1
0.7619 Intermediate Similarity NPD7473 Discontinued
0.761 Intermediate Similarity NPD5403 Approved
0.7593 Intermediate Similarity NPD37 Approved
0.7584 Intermediate Similarity NPD3027 Phase 3
0.7564 Intermediate Similarity NPD8166 Discontinued
0.7561 Intermediate Similarity NPD4966 Approved
0.7561 Intermediate Similarity NPD4965 Approved
0.7561 Intermediate Similarity NPD4967 Phase 2
0.755 Intermediate Similarity NPD943 Approved
0.7533 Intermediate Similarity NPD3764 Approved
0.7533 Intermediate Similarity NPD6798 Discontinued
0.7515 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7484 Intermediate Similarity NPD5401 Approved
0.7483 Intermediate Similarity NPD9545 Approved
0.7471 Intermediate Similarity NPD7228 Approved
0.7469 Intermediate Similarity NPD6599 Discontinued
0.7466 Intermediate Similarity NPD9269 Phase 2
0.7453 Intermediate Similarity NPD1653 Approved
0.7439 Intermediate Similarity NPD1465 Phase 2
0.7427 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD2935 Discontinued
0.7415 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD3455 Phase 2
0.7381 Intermediate Similarity NPD7199 Phase 2
0.7375 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD7033 Discontinued
0.7351 Intermediate Similarity NPD7095 Approved
0.7333 Intermediate Similarity NPD9494 Approved
0.7333 Intermediate Similarity NPD7819 Suspended
0.7321 Intermediate Similarity NPD5494 Approved
0.732 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD1613 Approved
0.7317 Intermediate Similarity NPD7411 Suspended
0.7303 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD7435 Discontinued
0.7278 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6355 Discontinued
0.7255 Intermediate Similarity NPD4062 Phase 3
0.7244 Intermediate Similarity NPD1510 Phase 2
0.7238 Intermediate Similarity NPD6535 Approved
0.7238 Intermediate Similarity NPD6534 Approved
0.7215 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD1549 Phase 2
0.7212 Intermediate Similarity NPD6386 Approved
0.7212 Intermediate Similarity NPD6385 Approved
0.72 Intermediate Similarity NPD6559 Discontinued
0.7192 Intermediate Similarity NPD9268 Approved
0.7176 Intermediate Similarity NPD8127 Discontinued
0.7166 Intermediate Similarity NPD8320 Phase 1
0.7166 Intermediate Similarity NPD8319 Approved
0.7161 Intermediate Similarity NPD447 Suspended
0.716 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD919 Approved
0.716 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6777 Approved
0.7135 Intermediate Similarity NPD6779 Approved
0.7135 Intermediate Similarity NPD6776 Approved
0.7135 Intermediate Similarity NPD6781 Approved
0.7135 Intermediate Similarity NPD6778 Approved
0.7135 Intermediate Similarity NPD6780 Approved
0.7135 Intermediate Similarity NPD6782 Approved
0.712 Intermediate Similarity NPD7700 Phase 2
0.712 Intermediate Similarity NPD7699 Phase 2
0.7097 Intermediate Similarity NPD1240 Approved
0.7097 Intermediate Similarity NPD4060 Phase 1
0.7091 Intermediate Similarity NPD3226 Approved
0.7089 Intermediate Similarity NPD9570 Approved
0.7089 Intermediate Similarity NPD2796 Approved
0.7083 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD1247 Approved
0.7068 Intermediate Similarity NPD7874 Approved
0.7068 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2532 Approved
0.7055 Intermediate Similarity NPD2534 Approved
0.7055 Intermediate Similarity NPD2533 Approved
0.7055 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD4340 Discontinued
0.7041 Intermediate Similarity NPD7768 Phase 2
0.7022 Intermediate Similarity NPD8313 Approved
0.7022 Intermediate Similarity NPD8312 Approved
0.7019 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7039 Approved
0.7006 Intermediate Similarity NPD7240 Approved
0.7006 Intermediate Similarity NPD1607 Approved
0.7006 Intermediate Similarity NPD7038 Approved
0.7006 Intermediate Similarity NPD8368 Discontinued
0.7 Intermediate Similarity NPD1608 Approved
0.7 Intermediate Similarity NPD3749 Approved
0.6994 Remote Similarity NPD5242 Approved
0.6994 Remote Similarity NPD3926 Phase 2
0.6993 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6982 Remote Similarity NPD5353 Approved
0.6981 Remote Similarity NPD1551 Phase 2
0.6977 Remote Similarity NPD6959 Discontinued
0.6975 Remote Similarity NPD3887 Approved
0.6975 Remote Similarity NPD2354 Approved
0.6973 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6951 Remote Similarity NPD3146 Approved
0.6951 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6939 Remote Similarity NPD5536 Phase 2
0.6931 Remote Similarity NPD7697 Approved
0.6931 Remote Similarity NPD7698 Approved
0.6931 Remote Similarity NPD7696 Phase 3
0.6923 Remote Similarity NPD8435 Approved
0.6923 Remote Similarity NPD8455 Phase 2
0.6923 Remote Similarity NPD8361 Approved
0.6923 Remote Similarity NPD8360 Approved
0.6918 Remote Similarity NPD4198 Discontinued
0.6918 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6914 Remote Similarity NPD3750 Approved
0.6914 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4110 Phase 3
0.6895 Remote Similarity NPD7870 Phase 2
0.6895 Remote Similarity NPD7871 Phase 2
0.6894 Remote Similarity NPD4534 Discontinued
0.6889 Remote Similarity NPD8407 Phase 2
0.6879 Remote Similarity NPD825 Approved
0.6879 Remote Similarity NPD826 Approved
0.6875 Remote Similarity NPD7701 Phase 2
0.6875 Remote Similarity NPD5404 Approved
0.6875 Remote Similarity NPD5406 Approved
0.6875 Remote Similarity NPD5408 Approved
0.6875 Remote Similarity NPD5405 Approved
0.6871 Remote Similarity NPD9493 Approved
0.6855 Remote Similarity NPD7097 Phase 1
0.6853 Remote Similarity NPD3021 Approved
0.6853 Remote Similarity NPD3022 Approved
0.6849 Remote Similarity NPD2629 Approved
0.6839 Remote Similarity NPD6832 Phase 2
0.6835 Remote Similarity NPD1933 Approved
0.6829 Remote Similarity NPD7236 Approved
0.6821 Remote Similarity NPD1535 Discovery
0.6818 Remote Similarity NPD5647 Approved
0.6815 Remote Similarity NPD6663 Approved
0.6813 Remote Similarity NPD2799 Discontinued
0.6809 Remote Similarity NPD5048 Discontinued
0.6807 Remote Similarity NPD6273 Approved
0.68 Remote Similarity NPD17 Approved
0.6796 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6792 Remote Similarity NPD6653 Approved
0.6791 Remote Similarity NPD8485 Approved
0.679 Remote Similarity NPD5958 Discontinued
0.6788 Remote Similarity NPD4357 Discontinued
0.6788 Remote Similarity NPD7390 Discontinued
0.6786 Remote Similarity NPD7458 Discontinued
0.678 Remote Similarity NPD7799 Discontinued
0.6776 Remote Similarity NPD1481 Phase 2
0.6774 Remote Similarity NPD5736 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data